Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides

Journal of the American Chemical Society
Davide PantarottoAlberto Bianco

Abstract

Carbon nanotubes (NTs) are becoming highly attractive molecules for applications in medicinal chemistry. The main problem of insolubility in aqueous media has been solved by developing a synthetic protocol that allows highly water-soluble carbon NTs to be obtained. As a result, biologically active peptides can be easily linked through a stable covalent bond to carbon NTs. We have demonstrated that a bound peptide from the foot-and-mouth disease virus, corresponding to the 141-159 region of the viral envelope protein VP1, retained the structural integrity and was recognized by monoclonal and polyclonal antibodies. In addition, this peptide-NT conjugate is immunogenic, eliciting antibody responses of the right specificity. Such a system could be greatly advantageous for diagnostic purposes and could find future applications in vaccine delivery.

References

Nov 1, 1992·Journal of Biomolecular NMR·M PiottoV Sklenár
Oct 1, 1981·Analytical Biochemistry·V K SarinR B Merrifield
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·L L FranceF Brown
Sep 1, 1995·Journal of Biomolecular NMR·D S WishartB D Sykes
Dec 18, 2001·Journal of Molecular Recognition : JMR·C L Baird, D G Myszka
Aug 31, 2002·Angewandte Chemie·Alexander StarJ Fraser Stoddart
Dec 18, 2002·Accounts of Chemical Research·S NiyogiR C Haddon
Dec 20, 2002·Nature·Keith A WilliamsCees Dekker
Jun 3, 2002·Angewandte Chemie·Andreas Hirsch
Jul 12, 1999·Angewandte Chemie·Dan M J DobleMartin Schröder

❮ Previous
Next ❯

Citations

Nov 19, 2004·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Sep 1, 2005·Analytical and Bioanalytical Chemistry·G Gruner
Jun 7, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Young Jik KwonJean M J Fréchet
Jul 6, 2013·Accounts of Chemical Research·Matteo Calvaresi, Francesco Zerbetto
Sep 18, 2007·Accounts of Chemical Research·Maurizio PratoAlberto Bianco
Jun 26, 2009·Journal of the American Chemical Society·Jingyi ChenIwao Ojima
Jul 26, 2008·Nature Nanotechnology·Kostas KostarelosAlberto Bianco
Jan 27, 2005·Chemical Communications : Chem Comm·Alberto BiancoMaurizio Prato
Sep 2, 2005·Chemical Communications : Chem Comm·Kazuo SakuraiSeiji Shinkai
Mar 7, 2006·Chemical Communications : Chem Comm·Giorgia PastorinAlberto Bianco
May 8, 2009·Chemical Society Reviews·Xiaohui PengStanislaus S Wong
Feb 10, 2011·Chemical Communications : Chem Comm·Mime KobayashiIchiro Yamashita
Jul 22, 2011·Chemical Communications : Chem Comm·Alberto BiancoMaurizio Prato
Jan 18, 2006·Journal of Biomaterials Science. Polymer Edition·Zhongyi JiangChenqiu Lv
Sep 13, 2013·Journal of Nanobiotechnology·Riccardo Gottardi, Bruno Douradinha
Sep 20, 2007·PloS One·Michael R McDevittDavid A Scheinberg
Nov 11, 2008·International Journal of Nanomedicine·W Shane JourneayBaljit Singh
Oct 24, 2012·International Journal of Nanomedicine·Sandhya VardharajulaShree R Singh
Feb 10, 2007·Toxicological Reviews·John CurtisGary Krieger
Jul 1, 2009·Future Medicinal Chemistry·Julien OgierEric Doris
Oct 25, 2012·Applied Physics Letters·Ran ChenPu Chun Ke
Aug 25, 2007·Nanomedicine·W K WanDonna T Padavan
Mar 4, 2014·BioMed Research International·Giuseppe CirilloFrancesca Iemma
Aug 21, 2013·Advanced Drug Delivery Reviews·Bin Sheng WongGiorgia Pastorin
Aug 1, 2013·Advanced Drug Delivery Reviews·David A ScheinbergSimone Alidori
Jul 17, 2013·Advanced Drug Delivery Reviews·Alessia BattigelliAlberto Bianco
Jan 1, 2008·Nanoscale Research Letters·Yanmei YuBing Yan
May 6, 2009·Expert Opinion on Drug Delivery·Yitzhak Rosen, Noel M Elman
Nov 22, 2005·Expert Opinion on Drug Delivery·Alberto Bianco
Oct 1, 2010·Drug Delivery·Amit Kumar TiwariNarendra Kumar Jain
Jul 5, 2013·Journal of Drug Targeting·Neelesh Kumar Mehra, N K Jain
Jan 24, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hatem A F M HassanKhuloud T Al-Jamal
Feb 7, 2013·Colloids and Surfaces. B, Biointerfaces·Kaushik Mallick, André M Strydom
Oct 29, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Silvia Lorena Montes-FonsecaBlanca Sánchez-Ramírez
Dec 23, 2011·Translational Oncology·Christopher Scott BergerLon J Wilson
Dec 21, 2010·Journal of Molecular Graphics & Modelling·Uthumporn ArsawangSupot Hannongbua
Aug 4, 2009·Advanced Drug Delivery Reviews·Phong A TranThomas J Webster
Apr 4, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Orazio VittorioAlfred Cuschieri
Jun 14, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Marianna Foldvari, Mukasa Bagonluri
Jun 14, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Marianna Foldvari, Mukasa Bagonluri
Jun 6, 2009·Biotechnology Progress·Jithesh V Veetil, Kaiming Ye
Apr 27, 2007·Biotechnology Progress·Jithesh V Veetil, Kaiming Ye
Aug 4, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Amanda M SchrandAli F Syed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.